Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 417-425

  Hewett, Sandra J ^a   Uliasz, Tracy F ^a   Vidwans, Aniruddha S ^a   Hewett, James A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FLURBIPROFEN; KAINIC ACID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; VALERYLSALICYLIC ACID;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; EXCITATORY AMINO ACID AGONISTS; FLURBIPROFEN; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KAINIC ACID; MEMBRANE PROTEINS; MICE; N-METHYLASPARTATE; NEURONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034012175     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Adams J, Collaco-Moraes Y and de Belleroche J (1996) Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation. J Neurochem 66:6-13.
2. Akaike A, Kaneko S, Tamura Y, Nakata N, Shiomi H, Ushikubi F and Narumiya S (1994) Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 663:237-243.
3. Allgaier C and Meder W (1995) Cultured chick sympathetic neurons: Prostanoid EP1 receptor-mediated facilitation of noradrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 352:447-450.
4. Bhattacharyya DK, Lecomte M, Dunn J, Morgans DJ and Smith WL (1995) Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valeryl salicylic acid. Arch Biochem Biophys 317:19-24.
5. Breder CD, Dewitt D and Kraig RP (1995) Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 355:296-315.
6. Breder CD, Smith WL, Raz A, Masferrer J, Seibert K, Needleman P and Saper CB (1992) Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol 322:409-438.
7. Cazevieille C, Muller A, Meynier F, Dutrait N and Bonne C (1994) Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int 24: 395-398.
8. Cole DJ, Patel PM, Reynolds L, Drummond JC and Marcantonio S (1993) Temporary focal cerebral ischemia in spontaneously hypertensive rats: The effect of ibuprofen on infarct volume. J Pharmacol Exp Ther 266:1713-1717.
9. Collaco-Moraes Y, Aspey B, Harrison M and de Belleroche J (1996) Cyclooxygenase-2 messenger RNA induction in focal cerebral ischemia. J Cereb Blood Flow Metab 16:1366-1372.
10. Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S and Trzaskos JM (1994) Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91:11202-11206.
11. Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R and Clark JB (1998) Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 70:1366-1375.
12. DeWitt DL, Meade EA and Smith WL (1993) PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs. Am J Med 95:40S-44S.
13. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP and Choi DW (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377-6388.
14. Dumuis A, Sebben M, Haynes L, Pin JP and Bockaert J (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature (Lond) 336:68-70.
15. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S and Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
16. Greig GM, Francis DA, Falgueyret JP, Ouellet M, Percival MD, Roy P, Bayly C, Mancini JA and O'Neill GP (1997) The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. Mol Pharmacol 52:829-838.
17. Hewett SJ (1999) Interferon-gamma reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation. J Neuroimmunol 94:134-143.
18. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ and Trifan OC (1999) Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 31:551-557.
19. Iadecola C, Forster C, Nogawa S, Clark HB and Ross ME (1999) Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol (Berl) 98:9-14.
20. Kainu T, Wikstrom AC, Gustafsson JA and Pelto-Huikko M (1994) Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5:2481-2485.
21. Keller M, Jackisch R, Seregi A and Hertting G (1985) Comparison of the prostanoid forming capacity of neuronal and astroglial cells in primary cultures. Neurochem Int 7:655-665.
22. Kimura H, Okamoto K and Sakai Y (1985) Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. Brain Res 330:235-244.
23. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC and Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819.
24. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM and Lehmann JM (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323.
25. Koh JY and Choi DW (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83-90.
26. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG and Wahli W (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11:779-791.
27. Kukreja RC, Kontos HA, Hess ML and Ellis EF (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59: 612-619.
28. Kulmacz RJ, Pendleton RB and Lands WE (1994) Interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase: Interpretation of reaction kinetics. J Biol Chem 269:5527-5536.
29. Lafon-Cazal M, Pietri S, Culcasi M and Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature (Lond) 364:535-537.
30. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM and Kliewer SA (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-33410.
31. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC and Seibert K (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228-3232.
32. Meade EA, Smith WL and DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610-6614.
33. Miettinen S, Fusco FR, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, Narhi M, Hokfelt T and Koistinaho J (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 94:6500-6505.
34. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J and Graham SH (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 95:10954-10959.
35. Nogawa S, Zhang F, Ross ME and Iadecota C (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746-2755.
36. Reddy ST and Herschman HR (1994) Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 269:15473-15480.
37. Reddy ST and Herschman HR (1997) Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J Biol Chem 272:3231-3237.
38. Reynolds IJ and Hastings TG (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 15:3318-3327.
39. Rosenstock M, Danon A and Rimon G (1999) PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity. Biochim Biophys Acta 1440:127-137.
40. Sanfeliu C, Hunt A and Patel AJ (1990) Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res 526:241-248.
41. Sasaki T, Nakagomi T, Kirino T, Tamura A, Noguchi M, Saito I and Takakura K (1988) Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector. Stroke 19:1399-1403.
42. Sekiyama N, Mizuta S, Hori A and Kobayashi S (1995) Prostaglandin E2 facilitates excitatory synaptic transmission in the nucleus tractus solitarii of rats. Neurosci Lett 188:101-104.
43. Seregi A, Keller M and Hertting G (1987) Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res 404:113-120.
44. Smith WL, Marnett LJ and DeWitt DL (1991) Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49:153-179.
45. Smith WL and DeWitt DL (1995) Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 15:179-194.
46. Spencer AG, Woods JW, Arakawa T, Singer II and Smith WL (1998) Subcellular localization of prostaglandin endoperoxide H syntheses-1 and -2 by immunoelectron microscopy. J Biol Chem 273:9886-9893.
47. Swinney DC, Mak AY, Barnett J and Ramesha CS (1997) Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. J Biol Chem 272:12393-12398.
48. Tsubokura S, Watanabe Y, Ehara H, Imamura K, Sugimoto O, Kagamiyama H, Yamamoto S and Hayaishi O (1991) Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain. Brain Res 543:15-24.
49. Tugwood JD, Aldridge TC, Lambe KG, Macdonald N and Woodyatt NJ (1996) Peroxisome proliferator-activated receptors: Structures and function. Ann NY Acad Sci 804:252-265.
50. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA and Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.
51. Yoshida S, Ikeda M, Busto R, Santiso M, Martinez E and Ginsberg MD (1986) Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: Origin and fate of free fatty acids. J Neurochem 47:744-757.